Ophthalmic Drugs Market Top Leading Players with Strategies and Forecast 2027
The global ophthalmic drugs market is projected to grow at a significant CAGR of around 5% during the forecast period. the market growth is attributed to the increasing prevalence of various eye disorders that increase the demand for efficient treatment and hence drives the growth of the global ophthalmic drugs market.
To Request a Sample of our Report on Ophthalmic Drugs
Market: https://www.omrglobal.com/request-sample/ophthalmic-drugs-market
Geographically, the global ophthalmic drugs
industry is segmented into North America, Europe, Asia-Pacific and the Rest of
the World. North America is expected to hold a significant share in the global
market during the forecast period. This is attributed to the presence of
well-established healthcare infrastructure in the region. In addition, the increased
prevalence of ophthalmic disorders, rising prevalence of chronic diseases. The
leading causes of blindness in the region include cataract, diabetic
retinopathy (DRP), damaged cornea, macular degeneration, glaucoma, refractive
errors, and others.
Besides, the geriatric population plays a vital
role in expanding the market size as this population pool is at increased risk
of acquiring eye disorder. According to the Statistics Times, the population of
North America as of 2017 was 582.4 million. Half the population of North
America is over 40 years of age due to an increase in the average life
expectancy of people. As the elder people are more susceptible to cataracts and
other eye-related problems and creates scope for the market growth.
Whereas, the market in Asia-Pacific is driven by numerous factors including increasing government initiatives such as the National Programme for Control of Blindness. As per the estimation of the International Diabetes Federation (IDF) in 2018, 382 million people had diabetes globally, and by 2035, this number was predicted to rise to 592 million. 80% of this population lives in under-developed and developing countries, and of the total, more than 60% live in Asia, with almost one-third in China.
Major increases in the prevalence of diabetes have occurred in developing countries including India and China due to rapid and ongoing socio-economic transition and will likely lead to further rise. According to the International Diabetes Federation, in 2018, 79% of adults with diabetes were living in developing and under-developed countries some of which leads to diabetic retinopathy. Also, the World Health Organization states that China had the largest number with 8 million blind and 75 million visually impaired individuals. Thus, these factors altogether create opportunities for market growth.
·
Increased investments by the government concerning the
early diagnosis and treatment of diseases is likely to positively affect the
ophthalmic drug industry during the forecast period.
·
The Asia-Pacific region will register a significant
growth rate in the market during the forecast period.
·
Novel product launches and the geographical expansion
will be the key growth strategy adopted by the key players to sustain in the
market.
(Get 15% Discount on Buying this Report)
A
full Report of Ophthalmic Drugs Market is Available @ https://www.omrglobal.com/industry-reports/ophthalmic-drugs-market
Global Ophthalmic Drugs Market – Segmentation
By Indication
·
Dry Eye
·
Eye Allergy
·
Glaucoma
·
Eye Infection
·
Retinal Disorders
·
Others
By Drug Class
·
Anti-Glaucoma Drugs
·
Anti-Allergy Drugs
·
Anti-Inflammatory Drugs
·
Anti-Vascular Endothelial Growth Factor (Anti-VEGF)
Agents
Global Ophthalmic Drugs Market – Segmentation by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Acucela Inc.
·
AFT Pharmaceuticals Ltd.
·
Akron Inc.
·
Allergan PLC
·
Bayer AG
·
Bausch Health Companies Inc.
·
Daiichi Sankyo Co. Ltd.
·
EyePoint Pharmaceuticals Inc.
·
F. Hoffmann-La Roche Ltd.
·
Johnson & Johnson Services Inc.
·
Merck & Co., Inc.
·
Novartis International AG
·
Omeros Corp.
·
Otsuka Pharmaceutical Co. Ltd.
·
Oxurion NV.
·
Pfizer Inc.
·
Regeneron Pharmaceuticals, Inc.
·
Santen Pharmaceutical Co. Ltd.
·
Senju Pharmaceutical Co. Ltd.
·
Sun Pharmaceuticals Industries Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment